The rising interest in GLP-1 agonists for diabetes has sparked a discussion about delivery routes : skin-applied devices versus tablets . Traditionally , GLP-1 drugs were solely available in oral form, but https://gerardfrlc081851.bloggip.com/41365090/glp-1-skin-applications-vs-pills-is-right-for-the-patient